# US 2020/0263205 A1 · Methods for genomic integration for kluyveromyces host cells

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0263205 A1
- Document ID: US20200263205A1
- Status: Published application
- Kind: A1
- Application number: 16/646,028
- Filed: 2018-09-12
- Published: 2020-08-20
- Earliest claimed: 2017-09-18
- Assignees: Amyris, Inc.
- Applicants: Amyris, Inc.
- Inventors: Jessica WALTER
- Web page: https://patentgrep.com/patent/US20200263205A1

## CPC

- C12N 15/905: {in yeast}
- C12N 9/226: {Class 2 CAS enzyme complex, e.g. single CAS protein}
- C12N 15/102: {Mutagenizing nucleic acids}
- C12N 15/11: DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology, C07H21/00); {Non-coding nucleic acids having a biological activity}
- C12N 15/815: {for yeasts other than Saccharomyces}
- C12N 2310/20: involving clustered regularly interspaced short palindromic repeats [CRISPR]
- C12N 2800/80: Vectors containing sites for inducing double-stranded breaks, e.g. meganuclease restriction sites
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present invention provides high efficiency targeted and marker-less single or simultaneous multiple integrations using nucleases and a stable plasmid in Kluyveromyces host cells.

## Claims

### Claim 1

A method of modifying a target site in a Kluyveromyces host cell genome, the method comprising:
(a) contacting the host cell, which has reduced non-homologous end joining (NHEJ) activity, with:
(i) a first linear nucleic acid capable of homologous recombination with itself or with one or more additional linear nucleic acids contacted with the host cell, whereby homologous recombination in the host cell results in formation of a circular extrachromosomal nucleic acid comprising a coding sequence for a selectable marker and a stability element comprising a centromere sequence (CEN) sequence at least 95% identical to SEQ ID NO: 2 and an autonomously replicating sequence (ARS) consensus sequence at least 90% identical to SEQ ID NO: 3;
(ii) a nuclease capable of cleaving the target site; and
(iii) a donor DNA molecule capable of homologous recombination at the cleaved target site, whereby homologous recombination in the host cell results in integration of the donor linear nucleic acid at the target site; and
(b) selecting a transformed host cell expressing the selectable marker.

### Claim 2 (depends on 1)

The method of claim 1, wherein the stability element is at least 90% identical to a sequence less than 750 bp in length and comprising residues 202 to 876 of SEQ ID NO: 1.

### Claim 3 (depends on 1)

The method of claim 1, wherein the stability element is at least 95% identical to SEQ ID NO: 1.

### Claim 4 (depends on 1)

The method of claim 1, wherein the host cell is K. marxianus.

### Claim at position 5

-7. (canceled)

### Claim 8 (depends on 1)

The method of claim 1, wherein the nuclease is an RNA-guided DNA endonuclease.

### Claim at position 7

-12. (canceled)

### Claim 13 (depends on 1)

The method of claim 1, wherein the NHEJ is reduced by integrating the nucleic acid encoding the RNA-guided endonuclease at YKU70 or YKU80 loci.

### Claim 14

A method for modifying a target site in a Kluyveromyces host cell genome, the method comprising:
(a) contacting the host cell, which has reduced non-homologous end joining (NHEJ) activity, with:
(i) a nucleic acid molecule comprising a stability element comprising a centromere sequence (CEN) sequence at least 95% identical to SEQ ID NO: 2 and an autonomously replicating sequence (ARS) consensus sequence at least 90% identical to SEQ ID NO: 3 and nucleic acid sequence encoding a nuclease capable of cleaving the target site; and
(ii) a donor DNA molecule capable of homologous recombination at the cleaved target site;
(b) selecting a transformed host cell in which the donor DNA molecule integrated into the target site.

### Claim 15 (depends on 14)

The method of claim 14, wherein the host cell is K. marxianus.

### Claim 16 (depends on 14)

The method of claim 14, wherein the nuclease is a meganuclease.

### Claim 17 (depends on 16)

The method of claim 16, wherein the meganuclease is F-CphI.

### Claim 18 (depends on 14)

The method of claim 14, wherein the stability element is at least 90% identical to a sequence less than 750 bp in length and comprising residues 202 to 876 of SEQ ID NO: 1.

### Claim 19 (depends on 14)

The method of claim 14, wherein the stability element is at least 95% identical to SEQ ID NO: 1.

### Claim 20 (depends on 14)

The method of claim 14, wherein the step of contacting includes contacting the host cell with two or more donor DNA molecules capable of homologous recombination with different target sites in the host cell genome, whereby homologous recombination in the host cell results in integration of the donor DNA molecules at the different target sites.

### Claim 21 (depends on 1)

A host cell made by the method of claim 1.

### Claim 22

A recombinant nucleic acid molecule comprising:
(i) a nucleic acid sequence encoding a nuclease or a sequence encoding a crRNA activity and a tracrRNA activity that enables site-specific recognition and cleavage of a target site by an RNA-guided DNA endonuclease; and
(ii) a stability element comprising a centromere sequence (CEN) sequence at least 95% identical to SEQ ID NO: 2 and an autonomously replicating sequence (ARS) consensus sequence at least 90% identical to SEQ ID NO: 3.

### Claim 23 (depends on 22)

The recombinant nucleic acid molecule of claim 22, wherein the stability element is at least 95% identical to a sequence less than 750 bp in length and comprising residues 202 to 876 of SEQ ID NO: 1.

### Claim 24 (depends on 22)

The recombinant nucleic acid molecule of claim 22, wherein the stability element is at least 95% identical to SEQ ID NO: 1.

### Claim 25 (depends on 22)

The recombinant nucleic acid molecule of claim 22, wherein the nuclease is an RNA-guided DNA endonuclease.

### Claim 26 (depends on 25)

The recombinant nucleic acid molecule of claim 25, wherein the RNA-guided DNA endonuclease is a Cas9 endonuclease.

### Claim 27 (depends on 22)

The recombinant nucleic acid molecule of claim 22, wherein the nuclease is a meganuclease.

### Claim 28 (depends on 27)

The recombinant nucleic acid molecule of claim 27, wherein the meganuclease is F-CphI.
